Product information and disease descriptionProduct descriptionProduct information
Co-prescribed/Concomitant therapies
1 evidence topic · 1 source
Proposed indication: UDCA combination therapy and monotherapy
| Proposed use | Quoted population |
|---|---|
| Combination with UDCA | “adults who have had an inadequate response to UDCA” |
| Monotherapy | “patients unable to tolerate UDCA” |